临床药剂师在社区中支持老年痴呆症患者的潜力:一种定性面试研究
Alice Burnand1, Abi Woodward2, Kumud Kantilal1
1Research Department of Primary Care and Population Health, Centre for Ageing Population Studies, University College London, London, UK.
British journal of clinical pharmacology
|July 9, 2025
概括
临床药剂师可以为痴呆症护理提供超越药物管理的整体支持. 增强信心,培训和工作场所支持对于他们对痴呆患者护理的有效贡献至关重要.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 初级医疗保健医学 一级医疗保健医学
背景情况:
- 全球痴呆症患病率的上升需要改善医疗保健管理.
- 临床药剂师是初级保健团队的关键成员,特别是在药物管理方面.
- 了解临床药剂师在痴呆症护理中的具体角色和经验至关重要.
研究的目的:
- 探索初级保健临床药剂师的观点和经验.
- 调查它们在支持社区居住的痴呆症患者中的作用.
主要方法:
- 在英格兰与初级保健临床药剂师进行了13次半结构面试.
- 使用反射主题分析来解释数据.
主要成果:
- 确定了三个关键主题:超越药物治疗的整体护理,药剂师在痴呆症护理团队中的不可或缺的作用,以及发展痴呆症护理方面的专业知识.
- 研究了医疗保健系统内的药剂师在痴呆症支持方面的能力.
结论:
- 临床药剂师可以在初级保健多学科团队内提供整体痴呆症支持.
- 积极的方法和超越药物管理的扩展角色是可行的.
- 药剂师的信心,适当的培训和支持性环境对于优化痴呆症护理贡献至关重要.
相关概念视频
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
Dementia
173
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
173
Alzheimer's Disease: Overview
675
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
675
Cognitive Development During Adulthood
296
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
296
Psychosis: Goals of Pharmacotherapy
213
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
213


